News
Merck trades at a low P/E with strong financials, Keytruda growth, and a solid 3.9% yield, while its pipeline offsets future risks. Read why MRK stock is a buy.
Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...
Investment in American manufacturing is on the rise, with pharmaceutical giant Merck recently announcing a landmark $1 billion investment to establish a manufacturing plant in Wilmington, Delaware.
We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Merck & Co., Inc. (NYSE:MRK) is one of ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
Merck & Co, a leading healthcare giant, has seen its shares plummet by 30% over the past year. Investors generally view the ...
For the second year running, New Jersey's Merck tops the list of responsible companies, highlighting a strong commitment to sustainability and social responsibility among local firms.
Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...
M&A deals announced worldwide in July included a rail merger, which is the largest transaction in the past 12 months based on ...
But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results